1887

Abstract

SUMMARY

The role of immune mechanisms in the pathogenicity of the M9 mutant of Semliki Forest virus (SFV) has been examined by the use of immune-deficient and immune-suppressed mice. In immune-competent BALB/c and C57BL/6 mice, the lesions in the central nervous system (CNS) were characterized by acute demyelinating meningo-encephalomyelitis. Myelin vacuolation and demyelination were more severe in BALB/c mice than in mice with a C57BL background. The mortality was 12% and 29% respectively. Treatment with cyclophosphamide or sodium aurothiomalate did not greatly alter the type of lesion produced, although mortality was increased. Lesions were less severe in nude (T-lymphocyte-deficient) mice and more severe in beige (natural killer cell-deficient) mice than in most immune-competent mice. Mortality was marginally increased in nude mice but not in beige mice. Demyelination in nude mice was followed rapidly by remyelination. Immune modification did not significantly alter the titres of virus in the brain at 7 days post-infection and infectious virus had been cleared from the brain by 14 days in all cases. Degenerating oligodendrocytes were detected in the CNS of all immune-modified mice examined at day 7. This study therefore suggests that both immune mechanisms and destruction of oligodendrocytes play a role in the production of demyelination by M9.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-1-73
1984-01-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/1/JV0650010073.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-1-73&mimeType=html&fmt=ahah

References

  1. Allner K., Bradish C. J., Fitzgeorge R., Nathanson N. 1974; Modification by sodium auro-thio-malate of the expression of virulence in mice by defined strains of Semliki Forest virus. Journal of General Virology 24:221–228
    [Google Scholar]
  2. Atkins G. J. 1983; The avirulent A7 strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain. Journal of General Virology 64:1401–1404
    [Google Scholar]
  3. Atkins G. J., Sheahan B. J. 1982; Semliki Forest virus neurovirulence mutants have altered cytopathogenicityfor central nervous system cells. Infection and Immunity 36:333–341
    [Google Scholar]
  4. Barrett P. N., Sheahan B. J., Atkins G. J. 1980; Isolation and preliminary characterization of Semliki Forest virus mutants with altered virulence. Journal of General Virology 49:141–147
    [Google Scholar]
  5. Berger M. L. 1980; Humoral and cell-mediated immune mechanisms in the production of pathology in avirulent Semliki Forest virus encephalitis. Infection and Immunity 30:244–253
    [Google Scholar]
  6. Blakemore W. F. 1973; Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. Journal of the Neurological Sciences 20:63–72
    [Google Scholar]
  7. Bradish C. J., Allner K., Fitzgeorge R. 1975a; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide. Journal of General Virology 28:225–237
    [Google Scholar]
  8. Bradish C. J., Allner K., Fitzgeorge R. 1975b; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of Myocrisin and 1-asparaginase. Journal of General Virology 28:239–250
    [Google Scholar]
  9. Chew-Lim M. 1979; Brain viral persistence and myelin damage in nude mice. Canadian Journal of Comparative Medicine 43:39–43
    [Google Scholar]
  10. Dal Canto M. C., Rabinowitz S. G. 1982; Experimental models of virus-induced demyelination of the central nervous system. Annals of Neurology 11:109–127
    [Google Scholar]
  11. Fazakerley J. K., Amor S., Webb H. E. 1983; Reconstitution of Semliki Forest virus-infected mice induces immune-mediated pathological changes in the CNS. Clinical and Experimental Immunology 52:115–120
    [Google Scholar]
  12. Jagelman S., Suckling A. J., Webb H. E., Bowen E. T. W. 1978; The pathogenesis of avirulent Semliki Forest virus infection in athymic nude mice. Journal of General Virology 41:599–607
    [Google Scholar]
  13. Kelly W. R., Blakemore W. F., Jagelman S., Webb H. E. 1982; Demyelination in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain. Neuropathology and Applied Neurobiology 8:43–53
    [Google Scholar]
  14. Lampert P. W., Sims J. K., Kniazeff A. 1973; Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscope studies. Acta neuropathologica 24:76–85
    [Google Scholar]
  15. Lando Z., Teitelbaum D., Arnon R. 1980; Induction of experimental allergic encephalomyelitis in genetically resistant strains of mice. Nature, London 287:551–553
    [Google Scholar]
  16. Lipsky P. E., Ziff M. 1976; Inhibition of antigen and mitogen-induced human lymphocyte proliferation by gold sodium thiomalate. Arthritis and Rheumatism 91:808–812
    [Google Scholar]
  17. Mazlo M., Tariska D., Arnon R. 1980; Morphological demonstration of the first phase of polyomavirus replication in oligodendroglia cells of human brain in progressive multifocal leukoencephalopathy (PML). Acta neuropathologica 49:133–144
    [Google Scholar]
  18. Mehta S., Webb H. E. 1982; Lysosomal enzyme changes in macrophages from mice given Myocrisin and infected with avirulent Semliki Forest virus. British Journal of Experimental Pathology 63:433–446
    [Google Scholar]
  19. Nagashima K., Wege H., Meyermann R., Ter Meulen V. 1978; Coronavirus-induced subacute demyelinating encephalomyelitis in rats: a morphological analysis. Acta neuropathologica 44:63–70
    [Google Scholar]
  20. Otu A. A., Russell R. J., White R. G. 1976; Biphasic pattern of activation of the reticuloendothelial system by anaerobic coryneforms in mice. Immunology 32:255–264
    [Google Scholar]
  21. Roder J., Dowe A. 1976; The beige mutation in the mouse selectively impairs natural killer cell function. Nature, London 278:451–453
    [Google Scholar]
  22. Sheahan B. J., Barrett P. N., Atkins G. J. 1981; Demyelination in mice resulting from infection with a mutant of Semliki Forest virus. Acta neuropathologica 53:129–136
    [Google Scholar]
  23. Sheahan B. J., Gates M. C., Caffrey J. F., Atkins G. J. 1983; Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus. Acta neuropathologica 60:257–265
    [Google Scholar]
  24. Suckling A. J., Jagelman S., Webb H. E. 1977; Brain lysosomal glycosidase activity in immunosuppressed mice infected with avirulent Semliki Forest virus. Infection and Immunity 15:386–391
    [Google Scholar]
  25. Suckling A. J., Pathak S., Jagelman S., Webb H. E. 1978; Virus-associated demyelination. A model using avirulent Semliki Forest virus infection of mice. Journal of the Neurological Sciences 39:147–154
    [Google Scholar]
  26. Suckling A. J., Jagelman S., Illavia S. J., Webb H. E. 1980; The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections. British Journal of Experimental Pathology 61:241–244
    [Google Scholar]
  27. Turk J. L., Parker D. 1982; Effect of cyclophosphamide on immunological control mechanisms. Immunological Reviews 65:99–113
    [Google Scholar]
  28. Wisniewski H. M., Lassman H., Brosnan C. F., Mehta P. D., Lidsky A. A., Madrid R. E. 1982; Multiple sclerosis: immunological and experimental aspects. Recent Advances in Clinical Neurology 3:95–124
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-65-1-73
Loading
/content/journal/jgv/10.1099/0022-1317-65-1-73
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error